Table 4 The distribution of hr HPV, overall and by specific genotypes among the women by HIV status
hr HPV status | All women n = 515 (%) | HIV positive n = 220 (%) | HIV negative n = 295 (%) | OR (95% CI) | |
|---|---|---|---|---|---|
Crude | Adjusteda | ||||
HR HPV negative | 414 (80.4) | 166 (75.4) | 248 (84.1) | 1 (ref) | 1 (ref) |
HR HPV positive | 101 (19.6) | 54 (24.6) | 47 (15.9) | 1.9 (1.2–2.9) | 1.7 (1.1-3.1) |
HPV 16 | 20 (3.9) | 14 (5.4) | 6 (2.6) | 3.3 (1.1-9.7) | 3.1 (1.3-6.3) |
HPV 18 | 12 (2.3) | 3 (1.4) | 9 (3.10 | 0.4 (0.1-1.8) | 0.4 (0.2-1.9) |
HPV 31 | 17 (3.3) | 12 (5.5) | 5 (1.7) | 3.1 (1.1-11.1) | 1.9 (0.9-8.1) |
HPV 33 | 2 (0.4) | 1 (0.5) | 1 (0.3) | 1.3 (0.0-49.3 | 1.1 (0.0-46.1) |
HPV 35 | 18 (3.5) | 13 (5.9) | 5 (1.7) | 3.4 (1.2-11.9) | 3.6 (1.4-6.9) |
HPV 39 | 3 (0.6) | 1 (0.5) | 2 (0.7) | 0.7 (0.1-9.4) | 0.6 (0.2-9.1) |
HPV 45 | 7 (1.4) | 3 (1.4) | 4 (1.4) | 1.0 (0.2-5.4) | 0.9 (0.1-5.9) |
HPV 51 | 10 (1.9) | 5 (2.3) | 5 (1.7) | 1.4 (0.3-5.4 | 1.4 (0.4-5.5) |
HPV 52 | 12 (2.3) | 6 (2.7) | 6 (2.0) | 1.4 (0.4-4.8) | 1.3 (0.2-5.1) |
HPV 56 | 6 (1.2) | 2 (0.9) | 4 (1.4) | 0.7 (0.1-4.3) | 0.7 (0.2-6.9) |
HPV 58 | 18 (3.5) | 9 (4.1) | 9 (3.5) | 1.4 (0.5-3.9) | 1.2 (0.3-4.1) |
HPV 59 | 3 (0.6) | 1 (0.5) | 2 (0.7) | 0.7 (0.02-9.4) | 0.5 (0.1-10.1) |
HPV 68 | 4 (0.8) | 1 (0.5) | 3 (1.0) | 0.4 (0.02-4.8) | 0.4 (0.1-6.1) |
Multiple HPV infection | 28 (5.4) | 18 (8.2) | 10 (3.9) | 2.5 (1.1-6.1) | 2.6 (1.3-5.3) |